drugset / Trial / NCT01784302

The Effect of Antacids and Multivitamins on Raltegravir

NCT01784302

Phase 1 Completed 15 enrolled Helen Reynolds
RandomizedParallel-groupOpen-labelTreatment

Summary

This study seeks to address the question of whether antacids or multivitamins influence the pharmacokinetics of raltegravir when co-administered. The aim of this study is to optimise the dosing of raltegravir when co-administered with antacids or multivitamins.

Timeline

Start
2014-04
Primary completion
2016-02
Completion
2016-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Maalox Plus extra Unknown
Comparator Raltegravir Other / unclassified 400 mg